The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...

Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...

The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic ...

Clinigen, a global specialist pharmaceutical services company, entered a strategic partnership with Tepsivo, a digital Pharmacovigilance (PV) services provider. As part of the partnership, Clinigen ...

ReiThera has inked a comprehensive Master Service Agreement (MSA) with SillaJen, which establishes ReiThera as the ...

Since its creation by a team of pharmaceutical, cold-chain management and quality assurance experts in 2004, Sentry BioPharma ...

The goal is to treat familial dysautonomia patients with a single injection.

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and ...

Advarra, a regulatory review solutions and clinical research technology, has unveiled its Study Collaboration solution ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.